PS Ratio: 135.67

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 135.67 is 2986% above its estimated 5-year average of 4.40, around the middle of its estimated 5-year range (0.78–301.85).

As of 2026-10-06T19:49:10.438Z. 9.18% below its estimated 12-month average of 149.39.

RNAC PS Ratio Metrics

P/S vs. estimated history

At 135.67, P/S is above its estimated 10-year median — higher than 82% of readings in its estimated 10-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Cartesian Therapeutics, Inc. (RNAC)?

The P/S ratio for RNAC stock is 135.67.

Is Cartesian Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 135.67 is 2986% above its estimated 5-year average of 4.40, around the middle of its estimated 5-year range (0.78–301.85).

What is the estimated TTM average P/S ratio for Cartesian Therapeutics, Inc. (RNAC)?

The estimated TTM average P/S ratio for RNAC stock is 149.39.

What is the estimated 3Y average P/S ratio for Cartesian Therapeutics, Inc. (RNAC)?

The estimated 3Y average P/S ratio for RNAC stock is 67.87.

What is the estimated 5Y average P/S ratio for Cartesian Therapeutics, Inc. (RNAC)?

The estimated 5Y average P/S ratio for RNAC stock is 4.40.

What is the estimated 10Y average P/S ratio for Cartesian Therapeutics, Inc. (RNAC)?

The estimated 10Y average P/S ratio for RNAC stock is 31.57.

Showing the most recent 260 of 2,586 data points. The chart above shows the full history.

Related Metrics